524494:BOM
IPCA Laboratories Ltd
1.920,40 ₹
arrow_upward
+1,19%(+22,55) 1d
13 d’oct., 15:50:06 GMT+5:30 · INR
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a 524494...
Obre
1.915,95 ₹
Alt
1.937,90 ₹
Baix
1.863,10 ₹
Capitalització borsària
487,04 kM
Volum mitjà
28,90 k
Volum
8,23 k
Dividend
0,31 %
Dividend trimestral
1,50 ₹
Data de l'exdividend
7 d’ag. 2026
Ràtio preu-benefici
37,20
Alt 52 setmanes
2.039,30 ₹
Baix 52 setmanes
1.252,95 ₹
BPA
51,63 ₹
Accions en circulació
126,35 M
Nombre d'empleats
17 k
Obre
1.915,95 ₹
Alt
1.937,90 ₹
Baix
1.863,10 ₹
Capitalització borsària
487,04 kM
Volum mitjà
28,90 k
Volum
8,23 k
Dividend
0,31 %
Dividend trimestral
1,50 ₹
Data de l'exdividend
7 d’ag. 2026
Ràtio preu-benefici
37,20
Alt 52 setmanes
2.039,30 ₹
Baix 52 setmanes
1.252,95 ₹
BPA
51,63 ₹
Accions en circulació
126,35 M
Nombre d'empleats
17 k
Notícies
De fonts web i partners de notícies
GBM
·
fa 21 hores
The News
Seeking Alpha
·
fa 43 minuts
Mentions of inflation have ballooned for tech companies – SoFi (SP500:)
Central Oregon Daily
·
fa 34 minuts
S&P 500 flat as chipmakers fall and bank earnings roll in
ChartMill
·
fa 57 minuts
What's going on in today's session: S&P500 most active stocks
Perfil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Sobre IPCA Laboratories Ltd